2000-2005

• Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress.  Proc Natl Acad Sci USA 102:4584-4589, 2005.  https://www.pnas.org/content/102/12/4584

• Bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic anti-multiple myeloma (MM) activity and overcome bortezomib resistance. Blood 103:3158-3169, 2004.  https://pubmed.ncbi.nlm.nih.gov/15070698/

• The novel synthetic triterpenoid, CDDO-Imidazolide, inhibits inflammatory response and tumor growth in vivo.  Clin Cancer Res 9:2798-2806, 2003. https://clincancerres.aacrjournals.org/content/9/7/2798

• The novel synthetic triterpenoid, CDDO-Imidazolide, inhibits inflammatory response and tumor growth in vivo.  Clin Cancer Res 9:2798-2806, 2003. https://clincancerres.aacrjournals.org/content/9/7/2798

• Synthetic oleanane and ursane triterpenoids with modified rings A and C:  A series of highly active inhibitors of nitric oxide production in mouse macrophages.  J Med Chem 43:4233-4246, 2000.  https://pubmed.ncbi.nlm.nih.gov/11063620/